Codes / ICD10CM / T40.715A

T40.715A Adverse effect of cannabis, initial encounter

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Adverse effect of cannabis, initial encounter

Summary

This ICD code applies to harmful or unintended reactions resulting from cannabis use, specifically during the initial encounter for management. It covers negative effects that arise from therapeutic or non-therapeutic cannabis exposure, including allergic reactions, side effects, or other adverse responses. The code is used when the adverse effect is the focus of the encounter and requires clinical attention.

Causes

Adverse effects may stem from therapeutic use, such as allergic reactions, or from non-therapeutic use, including overconsumption or interactions with other substances. They can result from the active compounds in cannabis, such as THC or CBD, triggering unexpected physiological or psychological responses.

Risk Factors

  • History of substance sensitivity or allergies.
  • Concurrent use of medications that interact with cannabis.
  • Inexperienced users or those with low tolerance.
  • Underlying health conditions affecting metabolism or response.
  • Use of high-potency cannabis products.

Symptoms

  • Allergic reactions (e.g., rash, swelling, difficulty breathing).
  • Psychiatric symptoms (e.g., anxiety, paranoia, psychosis).
  • Cardiovascular effects (e.g., increased heart rate, palpitations).
  • Gastrointestinal issues (e.g., nausea, vomiting, abdominal pain).
  • Neurological effects (e.g., dizziness, impaired coordination).

Diagnosis

Diagnosis involves a clinical evaluation of symptoms and a history of cannabis exposure. Healthcare providers assess the timing and nature of the reaction, ruling out other causes. Laboratory tests may be used to confirm cannabis presence but are not always necessary for diagnosis.

Treatment Options

  • Symptomatic management (e.g., antihistamines for allergies, benzodiazepines for anxiety).
  • Supportive care, including hydration and monitoring.
  • Discontinuation of cannabis use if the adverse effect is linked to exposure.
  • Referral to specialists for severe or persistent symptoms.

Prognosis and Follow-Up

Most adverse effects resolve with appropriate treatment and discontinuation of cannabis. Follow-up may be needed to monitor for recurrence or complications. Prognosis depends on the severity of the reaction and underlying health factors.

Complications

  • Severe allergic reactions (e.g., anaphylaxis).
  • Persistent psychiatric symptoms (e.g., anxiety disorders).
  • Cardiovascular events in high-risk individuals.
  • Respiratory issues from inhalation (e.g., bronchospasm).

Lifestyle & Prevention

  • Avoid cannabis if allergic or sensitive.
  • Use low-potency products and start with small doses.
  • Inform healthcare providers of cannabis use to avoid interactions.
  • Store products safely to prevent accidental exposure.

When to Seek Professional Help

Seek immediate care for severe symptoms (e.g., difficulty breathing, chest pain, severe confusion) or if symptoms worsen. Contact a provider for persistent or concerning reactions, even if mild.

Tips for Medical Coders

Document the nature of the adverse effect, the encounter type (initial), and any contributing factors (e.g., therapeutic use, allergy). Ensure the code is used only when the adverse effect is the primary reason for the encounter and not for poisoning or underdosing scenarios.

Medical Policies and Guidelines

Related policies from health plans

Book a walkthrough

T40.715A policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.